1-4 of 4
Edward Greenberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A First-in-Human Phase 1 Study of ABBV-525, a Small-Molecule MALT1 Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Andrew L. Sochacki, Jan A. Burger, Carrianne Ludwig, Wissam Assaily, Wijith Munasinghe, William Pappano, Edward Greenberg, Christine Will, Meghan C. Thompson
Journal: Blood
Blood (2023) 142 (Supplement 1): 3101.
https://doi.org/10.1182/blood-2023-181671
Published: 2023
Journal Articles

Discovery and Characterization of Macrocyclic Thiopeptide Proteasome Inhibitors for Hematologic Malignancies

Sridevi Ponduru, M.D., Raymond Moellering, Edward Greenberg, John Paul Ying-Ching Shen, M.D., Benjamin Z Stanton, James E. Bradner, M.D
Journal: Blood
Blood (2008) 112 (11): 3669.
https://doi.org/10.1182/blood.V112.11.3669.3669
Published: 2008
Journal Articles

A Soft-Drug Histone Deacetylase Inhibitor for Cutaneous T-Cell Lymphoma.

James Bradner, MD, Edward Greenberg, B.S., Sridevi Ponduru, M.D., Vishal Patel, B.S., Stuart Schreiber, Ph.D., Benjamin Rich, Ph.D., Ralph Mazitschek, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 800.
https://doi.org/10.1182/blood.V110.11.800.800
Published: 2007
Journal Articles

Targeting the Protein Degradation Pathway in Multiple Myeloma with Synergistic, Selective Small Molecules.

James Bradner, MD, John Paul Shen, BS, Edward Greenberg, BS, Teru Hideshima, MD, PhD, Kenneth C. Anderson, MD, Stuart L. Schreiber, PhD
Journal: Blood
Blood (2005) 106 (11): 2471.
https://doi.org/10.1182/blood.V106.11.2471.2471
Published: 2005